课题基金 / 基金详情

A Mucus-producing Intestinal Epithelium Model for In Vitro Drug Absorption Testing

A Mucus-producing Intestinal Epithelium Model for In Vitro Drug Absorption Testing
用于体外药物吸收测试的产生粘液的肠上皮模型
批准号:
10482521
负责人:
Christopher Eldridge Sims
金额:
$29.4万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-05-09 至 2023-10-31
关键词:
AcidsAcuteAntibodiesApicalArchitectureAutomobile DrivingBacteriaBasal CellBasic ScienceBiochemicalBiological ModelsBiological ProductsCaco-2 CellsCell CompartmentationCell Culture SystemCell Culture TechniquesCell Differentiation processCell modelCellsChronicClientColonColorectal CancerDataDevelopmentDifferentiation and GrowthDiseaseDoseDrug ModelingsEnsureEnterocytesEnteroendocrine CellEnvironmentEnzymesEpithelialEpithelial CellsEquilibriumFamily suidaeFoodFunctional disorderGastric MucinGastrointestinal DiseasesGastrointestinal tract structureGeometryGoalsGoblet CellsHarvestHumanImmuneIn VitroIndustryIndustry StandardInfiltrationInflammatoryInflammatory ResponseIntestinal MucosaIntestinesLarge IntestineMaintenanceMedicineMetabolismMicrobial BiofilmsMitoticModalityModelingMorphologyMovementMucous body substanceNatural ImmunityNutrientOrganoidsPathogenicityPharmaceutical PreparationsPharmacologic SubstancePhysiologicalPhysiologyPopulationProductionPropertyProtocols documentationRNAReagentReportingReproducibilityResearch SupportSamplingSmall IntestinesSourceStandard ModelSurfaceSystemTestingThickTimeToxic effectToxinTransverse colonVasoactive Intestinal Peptideabsorptionbacteriomebasebiomaterial developmentcell growthcell typecollegedrug developmentdrug discoveryexperiencegastrointestinalgastrointestinal epitheliumgene therapyhost microbiomehuman stem cellsimprovedin vitro Modelin vivointestinal epitheliumintestinal homeostasisjejunummeetingsmicrobialmicrobiomemicrobiome researchmicrobiotamicroorganismnovelnovel therapeuticsparticlepeptide drugpredictive modelingprogramsresearch and developmentrisk minimizationsample collectionscaffoldscale upsmall moleculestem cell differentiationstem cellssuccesstherapeutic evaluationtherapeutic targettwo-dimensional

项目摘要

项目成果

Christopher Eldridge Sims的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary The mucus layer is the first line of defense against infiltration of microorganisms, digestive enzymes and acids, digested food particles, microbial by-products, and food-associated toxins. This layer coats the interior surface of the GI tract, lubricates luminal contents and acts as a physical barrier to bacteria and other antigenic substances present in the lumen. The moist, nutrient-rich mucus layer adjacent to the epithelial barrier of the GI tract is also essential in the maintenance of intestinal homeostasis and contains a thriving biofilm including beneficial and pathogenic microbial populations. However, mucus has proven difficult to study, owing to it compositional and functional complexity and a substantial lack of either high-quality purified samples or cell- based culture systems containing mucus. This project will establish a gastrointestinal (GI) model for both harvesting physiologically relevant mucus and an epithelial culture system that possess a native mucus layer. Building on Altis’ capabilities to generate models with greater physiological relevance using donor-derived cells, this program will establish key protocols and workflows to ensure a reliable and reproducible mucus layer to additionally replicate in vivo GI morphology and function. In Aim 1, we will finalize in vitro protocols for mucus production in epithelia from both the small and large intestine (jejunum and transverse colon), which are well-described to production functionally distinct mucus. These data will establish key quality metrics enabling Altis to explore R&D studies with our industry and academic clients in diverse aspects of early stage of drug development and the development of inflammatory disease and microbiome research. Based on prior discussions with our pharmaceutical development customers, we view the commercial potential for this model as strong, especially given the unique capabilities of Altis’ current platform.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
InflammaGut: a drug-screenable co-culture system using gut-associated lymphocytes and autologous primary human gut epithelium that reports inflammation
  • 批准号:
    10483348
  • 项目类别:
  • 资助金额:
    $99.23万
  • 财政年份:
    2022
  • 负责人:
    Christopher Eldridge Sims
  • 依托单位:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
  • 批准号:
    10482465
  • 项目类别:
  • 资助金额:
    $25.66万
  • 财政年份:
    2022
  • 负责人:
    Christopher Eldridge Sims
  • 依托单位:
InflammaGut: a drug-screenable co-culture system using gut-associated lymphocytes and autologous primary human gut epithelium that reports inflammation
  • 批准号:
    10616555
  • 项目类别:
  • 资助金额:
    $98.84万
  • 财政年份:
    2022
  • 负责人:
    Christopher Eldridge Sims
  • 依托单位:
A 2D Intestinal Crypt Platform for Compound Screens
  • 批准号:
    10708947
  • 项目类别:
  • 资助金额:
    $90.03万
  • 财政年份:
    2021
  • 负责人:
    Christopher Eldridge Sims
  • 依托单位:
海外基金